Condition
Antiplatelet Effect
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04142151Not ApplicableUnknown
Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke
NCT02733640Not ApplicableCompletedPrimary
Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?
NCT00853450Phase 1CompletedPrimary
Bleeding Time Study With AZD6482, Clopidogrel and ASA
NCT00688714Phase 1CompletedPrimary
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
Showing all 4 trials